First case report of human monkeypox in Latin America: The beginning of a new outbreak.

Risk factors for mortality and clinical presentation of Monkeypox: a prospective cohort study in a HIV reference center

“…No patient in this study reported travel in the previous 21 days to areas of epidemiological interest, including European countries where the 2022 outbreak was initially detected. This suggests that the cases in our cohort were acquired in Mexico, contrary to early reports from other countries [7,22].…”

“…In 2022, an outbreak with unusual geographical distribution and epidemiologic characteristics led to the declaration of a global health emergency by the World Health Organization [6]. In Mexico, the first case was confirmed on May 28, 2022, in a 50-year-old man on preexposure prophylaxis who reported a trip to Amsterdam five days prior to the onset of symptoms [7]. At the time of writing, 5831 possible cases have been identified in Mexico, of which, 3509 were confirmed with molecular testing [8].…”

Severe mpox in patients with advanced AIDS: long-term disease and fatal outcome

“…Studies have demonstrated that the clinical and epidemiological features of the new mpox differ from those of the endemic mpox in Africa. Usually, the infection is self-limiting, and death is rare [1][2][3][4][5][6][7] .…”

“…In May 2022, the World Health Organization (WHO) raised an alert regarding human mpox transmission, and in July, the disease was declared a global health emergency 2,3 . The first case of mpox in Latin America was confirmed on May 18, 2022, in Mexico 4 . In Brazil, the first case of mpox occurred in São Paulo in a 41-year-old patient who had traveled to Portugal and Spain 5 .…”